Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Endometriosis With FFNP PET/MRI
NCT05480995Phase 2Active, not recruiting
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jan 2023
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluorofuranylnorprogesterone in endometriosis, sponsored by University of North Carolina at Chapel Hill. Started Jan 2023; status: active, not recruiting.
02
Drugs
fluorofuranylnorprogesterone
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT05480995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05480995.